
    
      Objective:

      Measurement of AUC, Cmax, tmax, t1/2 and clearance (Cl) of the protease inhibitor Kaletraâ„¢
      (lopinavir and ritonavir) each in the plasma of healthy individuals

        -  establish free and total plasma - blood cell concentration-relationship

        -  establish free and total plasma - saliva concentration-relationship

        -  establish blood cell concentration - drug transporter expression-relationship
    
  